For a tirzepatide powder preparation, the pharmacy specifies the diluent, amount and handling method. Never shake it. The final solution volume and total mass set the strength in mg/mL. That strength sets how many units you draw. Your pharmacy's instructions control every step. This page explains what they mean. If you are new to the drug, start with our tirzepatide guide.
Key takeaways
- Brand Zepbound and Mounjaro come ready to inject. Only some compounded tirzepatide ships as a freeze-dried (lyophilized) powder that you reconstitute.
- For a hypothetical 10 mg total mass, final solution volumes of 1 mL, 2 mL and 0.5 mL correspond to 10, 5 and 20 mg/mL. Added liquid is not automatically the final solution volume. The pharmacy chooses the volume, not you.
- Use the handling method in the pharmacy instructions; a brand solution label does not establish a powder mixing method.
- After mixing, refrigerate at 2 to 8 C (36 to 46 F), do not freeze, protect from light, and follow the beyond-use date on the pharmacy label.
- Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro.
Tirzepatide powder: what you have and why it needs mixing
Lyophilized means freeze-dried. The term describes removal of water during preparation, but does not by itself establish stability during shipping or storage. Before you can inject it, you add sterile water back. The pharmacy supplies the specified diluent or identifies it in its instructions. A preservative in a diluent does not independently establish the prepared medication's storage period.
Some pharmacies ship tirzepatide already in solution. If your vial is a liquid, you do not mix anything. Check the label. If it says "for reconstitution" or lists a powder weight in mg without a mg/mL, you have a powder vial.
Tirzepatide mixing instructions, step by step
These existing preparation steps depend on the actual pharmacy instructions; the brand records do not validate one method for every powder preparation.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →| Step | What to do | Why |
|---|---|---|
| 1 | Wash your hands and lay out the powder vial, the bacteriostatic water, a sterile syringe, and alcohol swabs on a clean surface. | Reduces contamination. |
| 2 | Read the pharmacy label for the water volume, the resulting mg/mL and the beyond-use date. | These three numbers control everything that follows. |
| 3 | Wipe both rubber stoppers with alcohol and let them dry. | Standard aseptic practice. |
| 4 | Draw the specified water volume into the syringe. | The specified final volume determines the calculated concentration. |
| 5 | Insert the needle into the powder vial and aim the stream at the glass wall, not the powder. Push slowly. | The prescribed handling method is preparation-specific. |
| 6 | Remove the syringe and swirl the vial gently in circles. Do not shake. | Use the mixing method actually specified for the preparation. |
| 7 | Wait until the solution is fully clear. Look for particles or cloudiness. | The brand label says not to use a solution with particles or discoloration; apply the same rule. |
| 8 | Write the mixing date and the mg/mL on the vial. Refrigerate. | The pharmacy instructions establish the relevant date and temperature conditions. |
Source: general aseptic technique; storage and inspection rules from the Zepbound and Mounjaro prescribing information; volumes and dates from your pharmacy label.
If you prefer to watch, the reconstitution walkthrough video shows the steps on camera.
How much bacteriostatic water to mix with 5 mg or 10 mg of tirzepatide
The arithmetic requires the total mass and final solution volume. The label and preparation instructions supply those inputs; the calculation does not select a diluent or volume. Here is the arithmetic for the three concentrations we use as examples across this site.
| Powder in vial | Specified final solution volume | Resulting concentration | Units for a 2.5 mg dose | Units for a 5 mg dose |
|---|---|---|---|---|
| 10 mg | 0.5 mL | 20 mg/mL | 12.5 units | 25 units |
| 10 mg | 1 mL | 10 mg/mL | 25 units | 50 units |
| 10 mg | 2 mL | 5 mg/mL | 50 units | 100 units |
| 5 mg | 0.5 mL | 10 mg/mL | 25 units | 50 units |
| 5 mg | 1 mL | 5 mg/mL | 50 units | 100 units |
Source: arithmetic (mg divided by mL equals mg/mL; units equal mL times 100 on a U-100 syringe). Your pharmacy's stated volume controls.
A hypothetical 10 mg total mass in a final 1 mL contains four mathematical portions of 2.5 mg or two of 5 mg. That does not establish a four-week or two-week storage period. A larger water volume makes the draws bigger and easier to read, but a 5 mg dose at 5 mg/mL fills a whole 1 mL syringe. Do not change the volume to make the math "nicer" without asking the pharmacy. The dosing calculator guide and the calculator handle the conversion once you know your mg/mL.
Ten independent reverse checks
These hypothetical inputs use the final solution volume, not an assumed diluent displacement. Amount / concentration gives mL; multiplying by 100 gives U-100 scale units. Reverse the calculation to check that the mass is unchanged.
| Concentration calculation | Mass input | Volume | U-100 equivalent | Mass reverse check |
|---|---|---|---|---|
| 10 mg / 0.5 mL = 20 mg/mL | 2.5 mg | 0.125 mL | 12.5 units | 12.5 / 100 x 20 = 2.5 mg |
| 10 mg / 0.5 mL = 20 mg/mL | 5 mg | 0.25 mL | 25 units | 25 / 100 x 20 = 5 mg |
| 10 mg / 1 mL = 10 mg/mL | 2.5 mg | 0.25 mL | 25 units | 25 / 100 x 10 = 2.5 mg |
| 10 mg / 1 mL = 10 mg/mL | 5 mg | 0.5 mL | 50 units | 50 / 100 x 10 = 5 mg |
| 10 mg / 2 mL = 5 mg/mL | 2.5 mg | 0.5 mL | 50 units | 50 / 100 x 5 = 2.5 mg |
| 10 mg / 2 mL = 5 mg/mL | 5 mg | 1 mL | 100 units | 100 / 100 x 5 = 5 mg |
| 5 mg / 0.5 mL = 10 mg/mL | 2.5 mg | 0.25 mL | 25 units | 25 / 100 x 10 = 2.5 mg |
| 5 mg / 0.5 mL = 10 mg/mL | 5 mg | 0.5 mL | 50 units | 50 / 100 x 10 = 5 mg |
| 5 mg / 1 mL = 5 mg/mL | 2.5 mg | 0.5 mL | 50 units | 50 / 100 x 5 = 2.5 mg |
| 5 mg / 1 mL = 5 mg/mL | 5 mg | 1 mL | 100 units | 100 / 100 x 5 = 5 mg |
At 20 mg/mL, 12.5 U-100 units represents 0.125 mL and 2.5 mg. A hypothetical whole-unit rounding to 13 gives 2.6 mg, a 4% difference; rounding to 12 gives 2.4 mg, a -4% difference. These checks expose the difference, not a clinical rounding rule.
Storage after mixing
The brand labels describe storage for their particular tirzepatide solutions: refrigerate at 2 to 8 C (36 to 46 F), do not freeze, and protect from light. The current brand records distinguish single-dose pens/vials (up to 21 total days at room temperature no higher than 30 C/86 F) from multi-dose vials and KwikPens (different 30-day and first-use conditions). Those numbers are for Zepbound and Mounjaro. A reconstituted compounded vial follows the beyond-use date and temperature directions on the pharmacy label, which can be shorter. If a mixed vial was frozen, left warm longer than the label allows, or turned cloudy, do not use it. Our page on what happens if tirzepatide gets warm goes deeper.
Drawing your dose from the mixed vial
Once mixed, treat the vial like any liquid compounded tirzepatide. Wipe the stopper, draw air equal to your dose into the syringe, inject the air into the vial, turn the vial upside down, and pull back to your unit mark. Check for large bubbles and tap them out. The amount and schedule are those specified for the actual prescription; the brand titration section does not choose a compounded preparation's mass-to-volume conversion. Full technique is in how to inject with a syringe.
What this means for compounded tirzepatide
Reconstitution is a compounded-product task. It is one more place where a mistake can change your dose, which is why the pharmacy's label matters more than any web page. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro. FDA has raised concerns about unapproved GLP-1 products, including dosing errors, so use only a vial dispensed under a prescription from a state-licensed pharmacy, with written mixing instructions.
At FormBlends, compounded tirzepatide is $149 for the first month, then $239 a month, or $214 a month with Subscribe & Save. Injection supplies are included and the price is the same at every dose. Medication is compounded by state-licensed 503A compounding pharmacies and shipped cold-chain. See pricing or begin at start.
Frequently Asked Questions
How do I mix tirzepatide?
Add the bacteriostatic water volume printed on your pharmacy label, aiming the stream at the vial wall, then swirl gently until clear. Do not shake. Label the vial with the date and concentration and refrigerate it.
How much bacteriostatic water do I mix with 5 mg of tirzepatide?
Whatever your pharmacy specifies. For a 5 mg total mass and specified final solution volume, 0.5 mL corresponds to 10 mg/mL and 1 mL to 5 mg/mL. The volume changes your unit count, so use the pharmacy's number and write the resulting mg/mL on the vial.
How much reconstitution solution do I use for 10 mg of tirzepatide?
Again, the pharmacy's stated volume. For example, 10 mg in a final 1 mL is 10 mg/mL, so a 2.5 mg input corresponds to 25 U-100 units. A final 2 mL is 5 mg/mL and the same mass corresponds to 50 units.
Can I shake tirzepatide powder to dissolve it faster?
No. Swirl the vial gently and give it time. The specified preparation method controls; the cited brand solution records do not test different powder mixing methods.
How long does mixed tirzepatide last in the fridge?
Use the beyond-use date on your pharmacy label; it is set for that specific product. The 21-day figure is for brand single-dose containers; multi-dose containers have different instructions. Neither establishes the storage period of a compounded vial you mixed yourself.
What if the mixed solution is cloudy or has particles?
Do not inject it. The brand label tells users not to use tirzepatide that has particles or discoloration, and the same caution applies to a compounded vial. Call the pharmacy that dispensed it.
Sources
- Zepbound (tirzepatide) prescribing information, Eli Lilly, current product record checked October 3, 2026.
- Mounjaro (tirzepatide) prescribing information, Eli Lilly, current product record checked October 3, 2026.
- Compounding and the FDA: Questions and Answers, U.S. Food and Drug Administration.
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration.
- FormBlends pricing, Form Blends LLC, verified September 5, 2026.
Next steps
Convert your mixed concentration to units on the tirzepatide dosage chart, then follow the syringe steps. Browse the tirzepatide hub for every other tirzepatide question. If anything on your label is unclear, talk to the pharmacist or a clinician before you mix. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →